Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria

Communications Biology(2021)10.1038/s42003-021-01856-1Source: DataRank Database

Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria is a research paper published in Communications Biology (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (23)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Thomas R. Aunins ORCID,Colleen M. Courtney ORCID,Jocelyn K. Campos,Peter B. Otoupal ORCID,Keesha E. Erickson ORCID

Live enrichment

PubMed:30945415

National Science Foundation

Grant: DGE 1144083

United States Department of Defense | Defense Advanced Research Projects Agency

Grant: D17AP00024

National Science Foundation

Grant: 1144083

Graduate Research Fellowship Program (GRFP)

National Institutes of Health

Grant: 1S10RR026641-01

ABI Elite ESI-QqTOF Mass Spectrometry System

goldLicense: cc-by

publisherhttps://www.nature.com/articles/s42003-021-01856-1.pdf

publisherhttps://www.nature.com/articles/s42003-021-01856-1

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7955031

repositoryhttps://doaj.org/article/0271799d70ee4c3f8b4bf205f57be3d9

https://doi.org/10.1038/s42003-021-01856-1

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Peptide Nucleic AcidsMicrobial ViabilityQH301-705.5Enterobacteriaceae InfectionsComputational Biology3T3 CellsMicrobial Sensitivity TestsOligonucleotides, AntisenseProof of Concept StudyArticleAnti-Bacterial AgentsMiceRAW 264.7 CellsEnterobacteriaceaeDrug DesignDrug Resistance, Multiple, BacterialAnimalsHumansBiology (General)HeLa Cells

Sustainable Development Goals

SDG 3: 3. Good health